Benzinga | Nov 5, 2020 04:13PM EST

Coherus BioSciences Q3 EPS $0.33 Misses $0.41 Estimate, Sales $113.55M Miss $122.88M Estimate

Coherus BioSciences (NASDAQ:CHRS) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.41 by 19.51 percent. This is a 47.62 percent decrease over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $113.55 million which missed the analyst consensus estimate of $122.88 million by 7.59 percent. This is a 1.67 percent increase over sales of $111.68 million the same period last year.